tiprankstipranks
Sio Gene Therapies (GB:0JRU)
LSE:0JRU

Sio Gene Therapies (0JRU) Financial Statements

0 Followers

Sio Gene Therapies Financial Overview

Sio Gene Therapies's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Sio Gene Therapies is scheduled to report earnings on August 10, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT-$ -3.28M$ -8.53M$ -13.03M$ -25.45M
EBITDA-$ -3.28M$ -8.26M$ -12.78M$ -25.25M
Net Income Common Stockholders$ 4.02M$ -3.08M$ -8.41M$ -13.32M$ -25.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 46.10M$ 49.87M$ 54.77M$ 63.73M$ 81.91M
Total Assets$ 47.24M$ 53.75M$ 62.48M$ 75.08M$ 93.31M
Total Debt$ 0.00$ 4.00K$ 2.36M$ 2.52M$ 2.67M
Net Debt$ -46.10M$ -49.86M$ -52.41M$ -61.21M$ -79.24M
Total Liabilities$ 2.15M$ 4.83M$ 10.70M$ 14.73M$ 17.04M
Stockholders Equity$ 45.08M$ 48.91M$ 51.78M$ 60.35M$ 76.27M
Cash Flow-
Free Cash Flow$ -4.90M$ -5.10M$ -8.96M$ -18.18M$ -20.75M
Operating Cash Flow$ -4.90M$ -5.08M$ -8.68M$ -17.82M$ -20.61M
Investing Cash Flow-$ 177.00K$ -277.00K$ -359.00K$ -142.00K
Financing Cash Flow-$ 0.00$ 0.00$ 0.00$ 962.00K
Currency in USD

Sio Gene Therapies Earnings and Revenue History

Sio Gene Therapies Debt to Assets

Sio Gene Therapies Cash Flow

Sio Gene Therapies Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis